Trends and Disparities in Mortality Related to Aortic Aneurysm and Aortic Dissection in the United States (1999-2023): An Analysis Using the CDC WONDER Database - Scorecard - MDSpire

Trends and Disparities in Mortality Related to Aortic Aneurysm and Aortic Dissection in the United States (1999-2023): An Analysis Using the CDC WONDER Database

  • By

  • Lin Lv

  • Xuedi Gao

  • Jia Li

  • Hong lu Wang

  • Hongjia Zhang

  • Sichong Qian

  • Haiyang Li

  • March 3, 2026

  • 0 min

Share

Clinical Scorecard: Trends and Disparities in Mortality Related to Aortic Aneurysm and Aortic Dissection in the United States (1999-2023): An Analysis Using the CDC WONDER Database

At a Glance

CategoryDetail
ConditionAortic aneurysm (AA) and aortic dissection (AD)
Key MechanismsAA involves localized aortic dilation due to medial layer impairment; AD involves intimal tear creating a false lumen in the aortic media
Target PopulationAdults aged ≥ 25 years in the United States
Care SettingHospital and outpatient settings including surgical and endovascular interventions

Key Highlights

  • AA classified into thoracic (TAA) and abdominal (AAA) subtypes; AD classified by Stanford types A and B with differing prognosis and management
  • AA mortality in the US has declined overall, but TAA incidence has increased; AD incidence stable with reduced in-hospital mortality for type A
  • Significant disparities in mortality exist by sex, race/ethnicity, age, geographic region, and urbanization status

Guideline-Based Recommendations

Diagnosis

  • Use imaging modalities (e.g., chest imaging) for detection of TAA and AAA
  • Classify AD by Stanford system to guide management

Management

  • Conservative pharmacotherapy (β-blockers, statins) for low-risk unruptured AA (diameter <5 cm, asymptomatic)
  • Open surgical repair for ruptured AA and acute type A AD requiring urgent intervention
  • Endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) favored for ruptured AA, elderly patients, and complicated type B AD
  • Microsurgical clipping for complex aneurysms in selected younger patients
  • Optimal medical therapy for uncomplicated type B AD

Monitoring & Follow-up

  • Regular imaging surveillance for aneurysm size and progression
  • Monitor blood pressure and cardiovascular risk factors to prevent AD and AA progression

Risks

  • Hypertension, aging, smoking, atherosclerosis, obesity, and substance abuse increase risk
  • Delayed diagnosis and inadequate treatment contribute to higher mortality, especially in developing regions and disadvantaged populations

Patient & Prescribing Data

Adults ≥ 25 years with AA or AD in the United States

Pharmacotherapy with β-blockers and statins reduces rupture risk in low-risk AA; surgical and endovascular interventions tailored by disease type and patient factors

Clinical Best Practices

  • Early identification and risk stratification using imaging and clinical classification systems
  • Tailor management strategies based on aneurysm size, rupture status, dissection type, and patient comorbidities
  • Address disparities by improving healthcare access and targeted interventions in high-risk demographic groups
  • Implement preventive measures including smoking cessation and hypertension control
  • Utilize multidisciplinary approaches combining medical, surgical, and endovascular therapies

References

Original Source(s)

Related Content